- Home
- AZ vs GNLX Comparison
AZ vs GNLX Comparison
Compare AZ & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AZ | GNLX |
|---|---|---|
| Founded | 2018 | 2001 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.5M | 202.4M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | AZ | GNLX |
|---|---|---|
| Price | $6.48 | $4.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $20.00 | $19.75 |
| AVG Volume (30 Days) | ★ 475.6K | 140.8K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,463,000.00 | N/A |
| Revenue This Year | $1,343,857.60 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 41.45 | N/A |
| 52 Week Low | $5.00 | $1.99 |
| 52 Week High | $12.36 | $8.54 |
Technical Indicators
Market Signals| Indicator | AZ | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 56.19 | 40.94 |
| Support Level | $5.64 | $4.20 |
| Resistance Level | $6.59 | $4.37 |
| Average True Range (ATR) | 0.47 | 0.25 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 75.00 | 46.90 |
Price Performance
Historical ComparisonAbout AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.